Every year, thousands of patients and care givers across the globe face the dire situation of discovering that the medicine they need is unavailable to them.   

It could be that it is still in development, a discontinued line, or simply unavailable in the country they reside in. In these difficult times, patient advocacy organizations can play a critical role as a trusted resource for their patients for timely and accurate information about the process for accessing unlicensed medicines. As an organization committed to delivering the right medicine, to the right patient, at the right time, Clinigen Group can assist patient organizations to ensure they are providing the best information possible to their communities about obtaining ethical and compliant access to unlicensed medicines. 

Patient organizations that we proudly support: 

European Alliance for Access to Safe Medicines (EAASM)
Alliance for Safe Online Pharmacy (ASOP EU)
Global Genes
Eurordis
Genetic Disorders UK
CheckOrphan

Interested in talking with Clinigen Group? For more information, please contact info@clinigengroup.com.